Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46313
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGubareva, V. O.-
dc.contributor.authorPazhinsky, A. L.-
dc.contributor.authorLugovskoy, S. S.-
dc.contributor.authorDubovtsova, E. Y.-
dc.contributor.authorVain, D. S.-
dc.date.accessioned2022-04-24T10:40:10Z-
dc.date.available2022-04-24T10:40:10Z-
dc.date.issued2019-
dc.identifier.citationPharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experiment / V.O. Gubareva [et al.] // Research Results in Pharmacology. - 2019. - Vol. 5, № 3.- P. 43-55. - Doi: 10.3897/rrpharmacology.5.38730. - Refer.: p. 54-55.ru
dc.identifier.urihttp://dspace.bsu.edu.ru/handle/123456789/46313-
dc.description.abstractThe retinoprotective effect of the 11-amino acid fragment of darbepoetin PRK-002 on the models of hypertensive retinal angiopathy and hypertensive neuroretinopathy in Wistar rats was investigated in comparison with carbamylated darbepoetin and sulodexide. The study revealed angio- and neuroprotective activity of the 11-amino acid fragment of darbepoetin PRK-002 in correction of retinal injury formed on the background of hypertensionru
dc.language.isoenru
dc.subjectmedicineru
dc.subjectpharmacologyru
dc.subject11-amino acid fragment of darbepoetinru
dc.subjecthypertensive neuroretinopathyru
dc.subjectPRK-002ru
dc.subjectretinal angiopathyru
dc.subjectWistar ratsru
dc.titlePharmacological correction of morphofunctional retinal injury using 11-amino acid fragment of darbepoetin in the experimentru
dc.typeArticleru
Appears in Collections:Vol. 5, № 3

Files in This Item:
File Description SizeFormat 
Gubareva_Pharmacological.pdf2.94 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.